Metformin in Chronic Obstructive Pulmonary Disease
Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effect of a tablet medication, called
metformin, in flare-ups (exacerbations) of chronic obstructive pulmonary disease. The
investigators believe that metformin may effectively control the blood sugar level during
COPD exacerbations. This is important because there is evidence that a high blood sugar level
during exacerbations may be linked with a worse prognosis. The investigators also think that
metformin may have other potentially useful effects on inflammation, antioxidant levels, the
effectiveness of steroid treatment, and recovery.